Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Controlled Study to Evaluate the Safety and Efficacy of Allogeneic MesenCure for the Treatment of Pulmonary Manifestations in Patients With COVID19

NCT04716998 is registered in ClinicalTrials.gov with BonusBio Group Ltd as lead sponsor.

NCT NCT04716998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04716998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Controlled Study to Evaluate the Safety and Efficacy of Allogeneic MesenCure for the Treatment of Pulmonary Manifestations in Patients With COVID19
Lead sponsor
BonusBio Group Ltd
Phase
Phase 1/2
Overall status
Completed
Start date
January 14, 2021
Completion date
January 31, 2022
Enrollment
50 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

covid19